Journal of Clinical & Experimental Neuroimmunology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • J Clin Exp Neuroimmunol 8 : 203,

Unraveling the Role of Tumor Necrosis Factor in Neuroinflammation Linked to Parkinson's Disease and Therapies

Samara Urban De Oliva*
Environmental Department, Pario Psychology & Environmental Sciences, Dartmouth, Japan
*Corresponding Author : Samara Urban De Oliva, Environmental Department, Pario Psychology & Environmental Sciences, Dartmouth, Japan, Tel: 1187421953239, Email: SamaraOliva@gmail.com

Received Date: Sep 01, 2023 / Published Date: Sep 30, 2023

Abstract

Neurodegenerative diseases Parkinson's complaint is a progressive neurodegenerative complaint associated with neuroinflammatory responses that lead to the neurodegeneration of the dopaminergic neurons. These neuroinflammatory mechanisms involve colorful cytokines produced by the actuated glial cells. Tumor Necrosis factor α(TNF α) is one of the major intercessors of the neuroinflammation associated with neurodegeneration. TNF α has a binary part of neuroprotection and neurotoxicity in the brain. The effective pathways of TNF involve colorful signaling pathways transduced by the receptors TNFR1 and TNFR2. Effective remedial strategies have been produced targeting the neurotoxic gets of the Tumor Necrosis Factor and the associated neurodegeneration which includes the use of Dominant Negative Tumor Necrosis Factor

Citation: Oliva SU (2023) Unraveling the Role of Tumor Necrosis Factor inNeuroinflammation Linked to Parkinson's Disease and Therapies. J Clin ExpNeuroimmunol, 8: 203.

Copyright: © 2023 Oliva SU. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top